Riskpilot← Back to searchSign inGet full accessSKARPSYNT Ögonklinik AB
ABActiveOrg 5568533177Torggatan 19 1trTemporary employment agency activities and other human resource provisions · NACE 7820Est. 20111 employees
Revenue 2025
SEK 5,6M
+5% vs 2024
EBITDA margin
85.2%
+4% vs 2024
Equity ratio
2.2%
Financial strength
Net profit 2025
SEK 44K
+219% vs 2024
| Revenue | SEK 5,6M | +5% |
| EBITDA | SEK 4,8M | +4% |
| Net profit | SEK 44K | +219% |
| Total assets | SEK 18,2M | +8% |
| Equity | SEK 401K | +12% |
| Employees | 1 | — |
Legal name
SKARPSYNT Ögonklinik AB
Org number
5568533177
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
18 maj 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva ögon läkarmottagning, övrig medicinsk mottagning, ögon kirurgi, utbildning och uthyrning av personal inom ramen för bolagets verksamhet.
Address
Torggatan 19 1tr
Email
skarpsyntogonklinik@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 477 | 5 048 | 5 098 | 5 356 | 5 634 |
| Staff expenses | — | — | −583 | −596 | −563 |
| EBITDA | 3 708 | 4 031 | 4 220 | 4 605 | 4 801 |
| Depreciation & amort. | −371 | −339 | −38 | −42 | −57 |
| EBIT | 3 337 | 3 692 | 4 182 | 4 563 | 4 744 |
| Net financials | — | — | 0 | 1 | 0 |
| Profit before tax | −13 | −8 | −18 | −37 | 44 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −13 | −8 | −18 | −37 | 44 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 10 836 | 13 138 | 14 872 | 16 878 | 18 224 |
| Equity | 419 | 411 | 394 | 357 | 401 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 10 417 | 12 727 | 14 478 | 16 521 | 17 823 |
| Total debt | 10 417 | 12 727 | 14 478 | 16 521 | 17 823 |
EBITDA margin
85.2%
This company
15.8%
Market median
+439% vs market
20212025
Equity ratio
2.2%
This company
38.2%
Market median
-94% vs market
20212025
Return on equity
11.0%
This company
18.4%
Market median
+40% vs market
20212025
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20212025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20212025
Debt / equity
44.48×
This company
0.62×
Market median
-7074% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ Audit | Audit | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
I.See.u Holding AB
SKARPSYNT Ögonklinik AB Board members of SKARPSYNT Ögonklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Joel Erixon | Audit | 0 companies |
| Ali Mohammad Emami Ahari | Board of Directors | 0 companies |
| Hans Johan Sjösten | Board of Directors | 0 companies |
| Hans Hugo Emami | Deputy Board Member | 0 companies |